Nevirapine or lamivudine plus stavudine and indinavir: examples of 2-class versus 3-class regimens for the treatment of human immunodeficiency virus type 1.

about

Resistance profiles and adherence at primary virological failure in three different highly active antiretroviral therapy regimens: analysis of failure rates in a randomized study.Population pharmacokinetic analysis of indinavir in HIV-infected patient treated with a stable antiretroviral therapy.

P2860

Q45060352-2E2DF9B2-7FA9-4086-A214-22B1EB9B593D Q46504597-0A4232D8-C1AE-4EAD-9E9E-32EE0547EC20

P2860

Nevirapine or lamivudine plus stavudine and indinavir: examples of 2-class versus 3-class regimens for the treatment of human immunodeficiency virus type 1.

Item

http://www.wikidata.org/entity/Q44183256

description

2002 nî lūn-bûn

@nan

2002年の論文

@ja

2002年学术文章

@wuu

2002年学术文章

@zh

2002年学术文章

@zh-cn

2002年学术文章

@zh-hans

2002年学术文章

@zh-my

2002年学术文章

@zh-sg

2002年學術文章

@yue

2002年學術文章

@zh-hant

name

Nevirapine or lamivudine plus ...... immunodeficiency virus type 1.

@en

Nevirapine or lamivudine plus ...... immunodeficiency virus type 1.

@nl

type

Item

label

Nevirapine or lamivudine plus ...... immunodeficiency virus type 1.

@en

Nevirapine or lamivudine plus ...... immunodeficiency virus type 1.

@nl

prefLabel

Nevirapine or lamivudine plus ...... immunodeficiency virus type 1.

@en

Nevirapine or lamivudine plus ...... immunodeficiency virus type 1.

@nl

P1476

Nevirapine or lamivudine plus ...... immunodeficiency virus type 1.

@en

P2093

Agence Nationale de Recherches sur le SIDA (ANRS) 081 Study Group

http://www.w3.org/2001/XMLSchema#string

Agnès Certain

http://www.w3.org/2001/XMLSchema#string

Christine Jacomet

http://www.w3.org/2001/XMLSchema#string

Claude Lévy

http://www.w3.org/2001/XMLSchema#string

Jean-Pierre Aboulker

http://www.w3.org/2001/XMLSchema#string

Laurence Gérard

http://www.w3.org/2001/XMLSchema#string

Laurence Morand-Joubert

http://www.w3.org/2001/XMLSchema#string

Patrick Yéni

http://www.w3.org/2001/XMLSchema#string

Sonia Guiramand-Hugon

http://www.w3.org/2001/XMLSchema#string

Stéphane Rivet

http://www.w3.org/2001/XMLSchema#string

P2860

Rapid in vitro selection of human immunodeficiency virus type 1 resistant to 3'-thiacytidine inhibitors due to a mutation in the YMDD region of reverse transcriptase

Urological complaints in relation to indinavir plasma concentrations in HIV-infected patients

Importance of protease inhibitor plasma levels in HIV-infected patients treated with genotypic-guided therapy: pharmacological data from the Viradapt Study.

Antiretroviral therapy in adults: updated recommendations of the International AIDS Society-USA Panel.

Genotypic and phenotypic resistance patterns of human immunodeficiency virus type 1 variants with insertions or deletions in the reverse transcriptase (RT): multicenter study of patients treated with RT inhibitors

A randomized, double-blind trial comparing combinations of nevirapine, didanosine, and zidovudine for HIV-infected patients: the INCAS Trial. Italy, The Netherlands, Canada and Australia Study.

Mechanisms of virologic failure in previously untreated HIV-infected patients from a trial of induction-maintenance therapy. Trilège (Agence Nationale de Recherches sur le SIDA 072) Study Team).

Drug susceptibility in HIV infection after viral rebound in patients receiving indinavir-containing regimens.

3-year suppression of HIV viremia with indinavir, zidovudine, and lamivudine.

Indinavir concentrations and antiviral effect.

P304

1096-1105

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1086/342694

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Philippe Flandre

Gilles Peytavin

Odile Launay

P577

2002-10-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12384844

http://www.w3.org/2001/XMLSchema#string

Nevirapine or lamivudine plus stavudine and indinavir: examples of 2-class versus 3-class regimens for the treatment of human immunodeficiency virus type 1.

about

P2860

P2860

Nevirapine or lamivudine plus stavudine and indinavir: examples of 2-class versus 3-class regimens for the treatment of human immunodeficiency virus type 1.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698